1. Home
  2. AGNCM vs NAMSW Comparison

AGNCM vs NAMSW Comparison

Compare AGNCM & NAMSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGNCM
  • NAMSW
  • Stock Information
  • Founded
  • AGNCM N/A
  • NAMSW N/A
  • Country
  • AGNCM United States
  • NAMSW Netherlands
  • Employees
  • AGNCM 53
  • NAMSW 29
  • Industry
  • AGNCM Real Estate Investment Trusts
  • NAMSW Biotechnology: Pharmaceutical Preparations
  • Sector
  • AGNCM Real Estate
  • NAMSW Health Care
  • Exchange
  • AGNCM Nasdaq
  • NAMSW Nasdaq
  • Market Cap
  • AGNCM N/A
  • NAMSW N/A
  • IPO Year
  • AGNCM N/A
  • NAMSW N/A
  • Fundamental
  • Price
  • AGNCM $25.16
  • NAMSW $9.10
  • Analyst Decision
  • AGNCM
  • NAMSW
  • Analyst Count
  • AGNCM 0
  • NAMSW 0
  • Target Price
  • AGNCM N/A
  • NAMSW N/A
  • AVG Volume (30 Days)
  • AGNCM N/A
  • NAMSW N/A
  • Earning Date
  • AGNCM N/A
  • NAMSW N/A
  • Dividend Yield
  • AGNCM N/A
  • NAMSW N/A
  • EPS Growth
  • AGNCM N/A
  • NAMSW N/A
  • EPS
  • AGNCM N/A
  • NAMSW N/A
  • Revenue
  • AGNCM N/A
  • NAMSW N/A
  • Revenue This Year
  • AGNCM N/A
  • NAMSW N/A
  • Revenue Next Year
  • AGNCM N/A
  • NAMSW N/A
  • P/E Ratio
  • AGNCM N/A
  • NAMSW N/A
  • Revenue Growth
  • AGNCM N/A
  • NAMSW N/A
  • 52 Week Low
  • AGNCM N/A
  • NAMSW N/A
  • 52 Week High
  • AGNCM N/A
  • NAMSW N/A
  • Technical
  • Relative Strength Index (RSI)
  • AGNCM 50.65
  • NAMSW 48.40
  • Support Level
  • AGNCM $24.90
  • NAMSW $9.40
  • Resistance Level
  • AGNCM $25.33
  • NAMSW $10.14
  • Average True Range (ATR)
  • AGNCM 0.11
  • NAMSW 0.44
  • MACD
  • AGNCM -0.00
  • NAMSW -0.11
  • Stochastic Oscillator
  • AGNCM 55.21
  • NAMSW 27.78

About AGNCM AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock

AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage or real estate markets.

About NAMSW NewAmsterdam Pharma Company N.V. Warrant

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

Share on Social Networks: